(Q47228485)

12 January 2018

title

The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma (English)

1 reference

12 January 2018

1 reference

Sean C Dowdy

1

1 reference

12 January 2018

Sally A Mullany

2

1 reference

12 January 2018

Kathy R Brandt

3

1 reference

12 January 2018

Bonnie J Huppert

4

1 reference

12 January 2018

William A Cliby

5

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

12 January 2018

published in

Cancer

1 reference

12 January 2018

volume

101

1 reference

12 January 2018

issue

2

1 reference

12 January 2018

page(s)

346-352

1 reference

12 January 2018

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Neoadjuvant chemotherapy in stage X ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Neoadjuvant chemotherapy for advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Ovarian carcinoma: value of CT in predicting success of debulking surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Clinical results of CsI-detector-based dual-exposure dual energy in chest radiography.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre-and postcontrast, fat-suppressed MR imaging, with histologic correlation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRI.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20376

7 January 2021

Identifiers

DOI

10.1002/CNCR.20376

1 reference

12 January 2018

1 reference

12 January 2018